Weight-loss drug Belviq withdrawn over fears of cancer occurrence

The FDA has requested that Eisai - the manufacturer of Belviq, Belviq XR (lorcaserin) - voluntarily withdraws the weight-loss drug from the US market because a safety clinical trial has showed an increased occurrence of cancer. Eisai has submitted a... (more)

Group of women.jpg

14/02/20 - News

Owen Haskins

Post-op restrictive eating behaviours

Study examines post-op restrictive eating behaviours in females

A study examining restrictive eating behaviours in females following bariatric surgery has found patients reported three interacting entities leading to them developing these behaviours. The themes, according to researchers from Royal Holloway, University of London and Chelsea... (more)

bowden_hernia_ol.jpeg

12/02/20 - News

Owen Haskins

Hernia surgery recovery

Researchers develop model to predict hernia surgery recovery

A team of researchers at the University of Tennessee, Knoxville, TN, have developed a predictive model to examine if patients experience less pain and possibly have better recovery outcomes if their fears or emotional issues were addressed before surgery. Approximately 350,000... (more)

obesityaction_nutrition.jpg

11/02/20 - News

Owen Haskins

Endocrine obesity guidelines

ESC publishes endocrine work-up in obesity guidelines

European Society of Endocrinology has published guidelines recommending testing for all patients with obesity for thyroid function (given the high prevalence of hypothyroidism in obesity). The comprehensive guidelines also recommend hormonal testing for hypercortisolism, male... (more)

bariatricsurgeryedit.jpg

Post-op weight regain

Post-bariatric surgery weight regain may be population-specific

07/02/20

Approximately 20% of bariatric surgery patients will regain weight after two years and, according to researchers from Mexico, the factors...

liraglutide_injection.jpg

11/02/20 - News

Owen Haskins

NICE consultation

Liraglutide not recommended for adults with overweight and obesity

In a consultation document, the UK’s National Institute for Health and Care Excellence has decided not to recommend liraglutide (Saxenda, Novo Nordisk), within its marketing authorisation, for managing adult who are overweight and with obesity alongside a reduced-calorie diet... (more)

drugs.jpg

10/02/20 - News

Owen Haskins

Appetite regulation

Positive results for probiotic Hafnia alvei HA4597 on the weight loss

TargEDys has completion of its three months, randomised, double blind, placebo-controlled, multi-centre clinical study carried out on 229 subjects and evaluating the efficacy of Hafnia alvei HA4597 in the weight loss by regulation of the appetite.

Gut microbiota.jpg

10/02/20 - News

Owen Haskins

Gut microbiota

SAG-gel platform provides multiple draft genomes of the gut microbiota

Studies have shown that a way to promote the growth of such beneficial microorganisms and modulate their composition for a healthy balance is to add certain forms of fibre, such as inulin, to our diet. However, out of all the tens of trillions of microorganisms in the gut... (more)

More news

07/02/20 - Research

Mesoporous silica particles

Sigrid Therapeutics’ SiPore15 prevents weight gain in mice

Sigrid Therapeutics has announced the publication of a major study in mice demonstrating the enzyme-blocking effects of mesoporous silica particles (MSPs) introduced to the gut and the resulting effect on food efficiency and metabolic risk factors. Sigrid has previously performed clinical studies... (more)

07/02/20 - Research

Obesity-related healthcare costs

Higher risk obesity-related healthcare costs industry dependent

Although employees with obesity incur higher direct and indirect costs, the extent of obesity-related costs tends to be lower in some industrial sectors including healthcare, according to researchers Groupe d'analyse, Ltée, Montréal, QC, Canada. They found that employees of specific industries,... (more)

07/02/20 - Research

Post-op weight regain

Post-bariatric surgery weight regain may be population-specific

Approximately 20% of bariatric surgery patients will regain weight after two years and, according to researchers from Mexico, the factors influencing regain are still controversial but may be population-specific. They stress that early detection of the patients that are more likely to fail is... (more)

06/02/20 - Research

GPER-selective agonist

Cancer-fighting compound combats obesity and diabetes in mice

G-1, a cancer-fighting compound currently in phase 1 clinical trials for cancer, reduces fat in obese mice, according to researchers led by a team from the University of New Mexico Health Science Center. In the paper, ‘Preclinical efficacy of the GPER-selective agonist G-1 in mouse models of... (more)

05/02/20 - Policy

Waist circumference and obesity

Waist circumference and BMI should be routinely measured

Healthcare professionals should routinely measure waist circumference alongside BMI to properly assess and manage obesity-related health risk, according to a Consensus Statement from the International Atherosclerosis Society (IAS) and International Chair on Cardiometabolic Risk (ICCR), who state... (more)

03/02/20 - Research

Access to surgery

Number of bariatric procedures increases but access remains low

Although the number of bariatric procedures in the US over the last 20 years has increased, access to surgery remains low despite a growing number of patients that are considered eligible for surgery, according to researchers from the Division of Bariatric and Gastrointestinal Surgery, Virginia... (more)